Cargando…
The curcumin analog EF24 is a novel senolytic agent
Cellular senescence is a hallmark of aging because senescent cells (SCs) accumulate with aging and play a causative role in age-related diseases. Selectively eliminating SCs has been emerging as a new strategy for treating age-related diseases and extending healthspan. Curcumin and its analogs have...
Autores principales: | Li, Wen, He, Yonghan, Zhang, Rongping, Zheng, Guangrong, Zhou, Daohong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366974/ https://www.ncbi.nlm.nih.gov/pubmed/30694217 http://dx.doi.org/10.18632/aging.101787 |
Ejemplares similares
-
Bioactivities of EF24, a Novel Curcumin Analog: A Review
por: He, Yonghan, et al.
Publicado: (2018) -
Discovery of piperlongumine as a potential novel lead for the development of senolytic agents
por: Wang, Yingying, et al.
Publicado: (2016) -
Oxidation resistance 1 is a novel senolytic target
por: Zhang, Xin, et al.
Publicado: (2018) -
In Vivo and In Vitro Suppression of Hepatocellular Carcinoma by EF24, a Curcumin Analog
por: Liu, Haitao, et al.
Publicado: (2012) -
Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic Development
por: Hu, Li, et al.
Publicado: (2022)